New Regulatory Guidelines Affecting QC Protocols

The recent updates from the FDA regarding quality control in laboratory settings highlight some significant changes that we need to integrate into our current protocols. It’s crucial for us to stay ahead of these adjustments to ensure compliance and maintain the integrity of our results. Does anyone else have insights on how they’re adapting their QC measures in light of these changes?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠​‌‍​‌‌‍​‍‌⁠‌​‌‍‌‌‌‍​⁠‌‍‍​‌‍⁠‍‌‍‍‌‌‍​⁠‌‍‍‌‌‍​‌‌‍⁠‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‍‌​⁠​‍​⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​​⁠​⁠​⁠‌⁠​​‌​​‌‌‍⁠​‌​​⁠‌‌‌⁠‌⁠​​​⁠​‍‌​⁠‍‌​‌‍‌‍​‌‌‍​‍‌⁠‍​‌‌​​‌⁠‍‍​‍​‍‌⁠⁠‌​